207 related articles for article (PubMed ID: 35269607)
21. Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors.
Li J; Deng Y; Zhang W; Zhou AP; Guo W; Yang J; Yuan Y; Zhu L; Qin S; Xiang S; Lu H; Gong J; Xu T; Liu D; Shen L
J Hematol Oncol; 2021 Jun; 14(1):95. PubMed ID: 34154614
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency.
Cohen R; Pellat A; Boussion H; Svrcek M; Lopez-Trabada D; Trouilloud I; Afchain P; André T
Bull Cancer; 2019 Feb; 106(2):137-142. PubMed ID: 30327191
[TBL] [Abstract][Full Text] [Related]
23. Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.
Toh JWT; Phan K; Reza F; Chapuis P; Spring KJ
Int J Colorectal Dis; 2021 Aug; 36(8):1573-1596. PubMed ID: 33604737
[TBL] [Abstract][Full Text] [Related]
24. MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors.
Svrcek M; Lascols O; Cohen R; Collura A; Jonchère V; Fléjou JF; Buhard O; Duval A
Bull Cancer; 2019 Feb; 106(2):119-128. PubMed ID: 30713006
[TBL] [Abstract][Full Text] [Related]
25. Creation of a Quality Payment Program Measure for Mismatch Repair or Microsatellite Instability Biomarker Testing Status in Colorectal, Endometrial, Gastroesophageal, or Small Bowel Carcinoma.
Bocsi GT; Laudadio J; Jain R; Eakin SM; Bhalla A; Rosenberg JA; Maratt JK; Kupfer SS; Leiman DA; Cardona DM
Arch Pathol Lab Med; 2024 Jun; 148(6):728-734. PubMed ID: 37708308
[TBL] [Abstract][Full Text] [Related]
26. A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours.
Kang YJ; O'Haire S; Franchini F; IJzerman M; Zalcberg J; Macrae F; Canfell K; Steinberg J
Sci Rep; 2022 Nov; 12(1):20495. PubMed ID: 36443366
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathological features and types of microsatellite instability in 1394 patients with colorectal cancer].
Li X; Liu H; Liang M; Chen H; Liang L
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1645-1650. PubMed ID: 33243738
[TBL] [Abstract][Full Text] [Related]
28. Recent Applications of Artificial Intelligence from Histopathologic Image-Based Prediction of Microsatellite Instability in Solid Cancers: A Systematic Review.
Alam MR; Abdul-Ghafar J; Yim K; Thakur N; Lee SH; Jang HJ; Jung CK; Chong Y
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681570
[TBL] [Abstract][Full Text] [Related]
29. Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study.
Tougeron D; Sueur B; Zaanan A; de la Fouchardiére C; Sefrioui D; Lecomte T; Aparicio T; Des Guetz G; Artru P; Hautefeuille V; Coriat R; Moulin V; Locher C; Touchefeu Y; Lecaille C; Goujon G; Ferru A; Evrard C; Chautard R; Gentilhomme L; Vernerey D; Taieb J; André T; Henriques J; Cohen R;
Int J Cancer; 2020 Jul; 147(1):285-296. PubMed ID: 31970760
[TBL] [Abstract][Full Text] [Related]
30. Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer.
Colle R; Radzik A; Cohen R; Pellat A; Lopez-Tabada D; Cachanado M; Duval A; Svrcek M; Menu Y; André T
Eur J Cancer; 2021 Feb; 144():9-16. PubMed ID: 33316636
[TBL] [Abstract][Full Text] [Related]
31. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases].
Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997
[No Abstract] [Full Text] [Related]
32. Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer.
Dedeurwaerdere F; Claes KB; Van Dorpe J; Rottiers I; Van der Meulen J; Breyne J; Swaerts K; Martens G
Sci Rep; 2021 Jun; 11(1):12880. PubMed ID: 34145315
[TBL] [Abstract][Full Text] [Related]
33. Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair Status.
Walker R; Georgeson P; Mahmood K; Joo JE; Makalic E; Clendenning M; Como J; Preston S; Joseland S; Pope BJ; Hutchinson RA; Kasem K; Walsh MD; Macrae FA; Win AK; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Rosty C; Winship IM; Buchanan DD
J Mol Diagn; 2023 Feb; 25(2):94-109. PubMed ID: 36396080
[TBL] [Abstract][Full Text] [Related]
34. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing.
Smithgall MC; Remotti H; Hsiao SJ; Mansukhani M; Liu-Jarin X; Fernandes H
Hum Pathol; 2022 Jan; 119():41-50. PubMed ID: 34666078
[TBL] [Abstract][Full Text] [Related]
35. [Molecular epidemiology of microsatellite instability/mismatch repair deficiency in our institute - methodical aspects].
Nádorvári LM; Kiss A; Barbai T; Kulka J; Rásó E; Tímár J
Magy Onkol; 2023 Jun; 67(2):147-153. PubMed ID: 37314076
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer.
Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC
Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219
[TBL] [Abstract][Full Text] [Related]
37. Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T
Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654
[TBL] [Abstract][Full Text] [Related]
38. Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors.
Shimozaki K; Hayashi H; Tanishima S; Horie S; Chida A; Tsugaru K; Togasaki K; Kawasaki K; Aimono E; Hirata K; Nishihara H; Kanai T; Hamamoto Y
Sci Rep; 2021 Oct; 11(1):20003. PubMed ID: 34625576
[TBL] [Abstract][Full Text] [Related]
39. Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer.
Inamori K; Togashi Y; Fukuoka S; Akagi K; Ogasawara K; Irie T; Motooka D; Kobayashi Y; Sugiyama D; Kojima M; Shiiya N; Nakamura S; Maruyama S; Suzuki Y; Ito M; Nishikawa H
JCI Insight; 2021 May; 6(9):. PubMed ID: 33755600
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and molecular consequences of microsatellite instability in human cancers].
Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A
Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
